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OBJECTIVES We sought to assess the prognostic value of alterations in left ventricular (LV) diastolic
function in patients with essential hypertension.
BACKGROUND Alterations in LV diastolic function are frequent in patients with hypertension, even in the
absence of LV hypertrophy, but their prognostic significance has never been investigated.
METHODS In the setting of the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA)
study, we followed, for up to 11 years (mean: 4.4 years), 1,839 Caucasian hypertensive
patients (50  12 years, 53% men, blood pressure (BP) 156/98 mm Hg) without previous
cardiovascular events, who underwent Doppler echocardiography and 24-h BP monitoring
before therapy. The early/atrial (E/A) mitral flow velocity ratio was calculated and corrected
for age and heart rate (HR).
RESULTS During follow-up, there were 164 major cardiovascular events (2.04 per 100 patient-years).
The incidence of cardiovascular events was 2.47 and 1.65 per 100 patient-years in patients
with an age- and HR-adjusted E/A ratio below (n  919) and above (n  920) the median
value, respectively (p  0.005 by the log-rank test). In Cox analysis, controlling for age,
gender, diabetes, cholesterol, smoking, LV mass and 24-h systolic BP (all p  0.05), a low
age- and HR-adjusted E/A ratio conferred an increased risk of cardiovascular events (odds
ratio 1.57, 95% confidence interval [CI] 1.11 to 2.18, p  0.01). A 21% excess risk was found
for each 0.3 decrease of the adjusted E/A ratio (95% CI from 2% to 43%; p  0.03).
CONCLUSIONS Impaired LV early diastolic relaxation, detected by pulsed Doppler echocardiography,
identifies hypertensive patients at increased cardiovascular risk. Such association is indepen-
dent of LV mass and ambulatory BP. (J Am Coll Cardiol 2002;39:2005–11) © 2002 by the
American College of Cardiology Foundation
Abnormalities of left ventricular (LV) diastolic filling have
often been described in patients with hypertension (1–7),
even in the absence of LV hypertrophy (2,5–7). Doppler
imaging of the mitral inflow has gained wide acceptance for
the evaluation of hypertensive patients, as a simple, nonin-
vasive and easily repeatable method of assessing LV diastolic
filling (8). Diastolic dysfunction in hypertensive patients is
characterized primarily by impaired isovolumic relaxation
(6,9). As a consequence, the velocity of early diastolic filling
decreases and the late atrioventricular gradient increases,
yielding a decreased early/atrial (E/A) velocity ratio (10).
Although they are only approximate and indirect mea-
sures of LV diastolic function (8), flow velocity-derived
indexes of diastolic filling are widely recommended for the
diagnosis of diastolic dysfunction (11), and they provide
independent prognostic information in different clinical
settings and populations, including congestive heart failure
(12), the early phases of myocardial infarction (13,14) and
the elderly (15). Hypertension is the most common risk
factor for congestive heart failure in the general population
(16) and is a frequent precursor of diastolic heart failure
(17). However, it is still debated whether an independent
prognostic value of LV diastolic dysfunction exists in
hypertensive patients. In particular, it is currently unknown
whether assessment of the LV inflow velocity pattern adds
to the prognostic information provided by LV mass (18,19).
In the setting of the Progetto Ipertensione Umbria Moni-
toraggio Ambulatoriale (PIUMA) study, we had the oppor-
tunity to investigate the relationship between abnormalities
of LV diastolic function, as detected by Doppler echocar-
diography, and the subsequent risk of cardiovascular morbid
events in patients with essential hypertension.
METHODS
The PIUMA study is a prospective follow-up study of
Caucasian adult patients with essential hypertension (20–
22). Hypertensive patients were referred to one of three
participating centers (Perugia, Citta` della Pieve and Cas-
tiglione del Lago) for baseline evaluation by a group of
general practitioners in Umbria, in central Italy. A total of
1,839 subjects enrolled between 1988 and 1996, who had
good-quality M-mode and Doppler echocardiographic re-
cordings and complete follow-up data available, were in-
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cluded in the present analysis. All patients fulfilled the
following criteria: 1) systolic blood pressure (BP) 140 mm
Hg, diastolic BP 90 mm Hg, or both, on three or more
office visits at one-week intervals; 2) no previous treatment
for hypertension (70%) or withdrawal from antihypertensive
drugs four or more weeks before the study; 3) no clinical or
laboratory evidence of heart failure, coronary heart disease,
atrial fibrillation, previous stroke, valvular defects (stenosis
or grade 1 regurgitation) or secondary causes of hyperten-
sion, or important concomitant disease; 4) good-quality
echocardiographic recordings (see subsequently); and 5) one
or more valid BP measurement per hour over 24 h. We
excluded from the present analysis all patients whose LV
ejection fraction at echocardiography was 0.50. All pa-
tients gave written or witnessed oral informed consent to
participate in the study.
Baseline measurements. Office BP was measured with a
mercury sphygmomanometer by a physician in the hospital
clinic, after the subject sat for 10 min. The average of
three or more measurements on two or more sessions was
considered for the analysis. Heart rate (HR) was measured
immediately after the echocardiographic study, by taking
the radial pulse for 1 min. Ambulatory BP was recorded
with an oscillometric device (Models 90202 and 90207,
SpaceLabs, Redmond, Washington) that was set to take a
reading every 15 min throughout 24 h. Reading, editing and
analysis of data were performed as previously described
(20,21).
The M-mode echocardiographic study of the LV was
performed under two-dimensional control. Details on read-
ing procedures and reproducibility in our laboratory are
reported elsewhere (22). The LV mass was calculated
according to Devereux et al. (23) and corrected by height2.7
to account for the effect of obesity (24).
Pulsed Doppler measurements of LV diastolic inflow
were obtained as reported previously (5). Briefly, the LV
diastolic filling pattern was recorded from the apical trans-
ducer position in patients in the partial left lateral decubitus
position during expiratory apnea, with the sample volume
situated between the mitral leaflet tips. The peak velocity of
early rapid filling (E velocity) and the peak velocity of atrial
filling (A velocity) were recorded, and the E/A ratio was
calculated. The time of E velocity deceleration was mea-
sured as the interval between the peak E velocity and the
point at which the descending segment of E-wave, or its
asymptote, crosses the zero-velocity line. Tracings were read
by two observers who were unaware of the patients’ clinical
data, and the mean value from five or more measurements
per observer was computed. Intra-observer between-
occasion reproducibility of the Doppler measures was as-
sessed in 20 consecutive hypertensive patients examined
twice, 7 days apart. The mean differences  SD were
0.001  0.049 m/s1 for peak E velocity, 0.006 
0.051 m/s1 for peak A velocity and 0.019  0.162 for the
E/A velocity ratio.
Follow-up procedures and end-point evaluation. All pa-
tients were followed by their family physicians, in cooper-
ation with the outpatient clinic of the referring hospital, and
treated through the implementation of standard lifestyle
and pharmacologic measures. Most patients continue to be
periodically referred to our institutions for BP control and
other diagnostic procedures. At the follow-up visit, 70% of
the study patients were taking antihypertensive drugs, and
30% were complying with lifestyle measures only. Diuretics,
beta-blockers, angiotensin-converting enzyme inhibitors,
Ca2 channel blockers and alpha1-blockers, alone or in
various combinations, were the antihypertensive drugs that
were most frequently prescribed. Periodic contact with the
family physician and telephone interviews were used to
determine the incidence of major cardiovascular complica-
tions of hypertension. For patients who developed a cardio-
vascular morbid event, hospital record forms and other
available original-source documents were reviewed by the
authors as a group. Cardiovascular events included new-
onset coronary artery disease (myocardial infarction, unsta-
ble angina with documentation of ischemic electrocardio-
graphic changes, sudden cardiac death or coronary
revascularization procedure), congestive heart failure that
required hospital admission, stroke, transient cerebral isch-
emia, symptomatic aorto-iliac occlusive disease verified by
angiography and end-stage renal disease. The international
standard criteria used to diagnose cardiovascular events in
the PIUMA study have been reported previously (20,22).
Statistical analysis. Parametric data are reported as the
mean value  SD. Standard descriptive and comparative
analyses were undertaken. The incidence of cardiovascular
events is presented as the number of events per 100
patient-years, based on the ratio of the number of events
observed to the total number of patient-years of exposure,
up to the terminating event or censor. For those patients
without events, the date of censor was that of the last
contact with the patient. For those patients who experi-
enced multiple events, survival analysis was restricted to the
first event. Survival curves were estimated by using the
Kaplan-Meier product-limit method and compared by us-
ing the Mantel (log-rank) test. The effect of prognostic
factors on survival was evaluated by using the stepwise Cox
semi-parametric regression model (25). The assumption of
linearity for the Cox model was tested through visual
inspection, and no violation of proportional hazards was
found. We tested the variables of age (years), gender, body
weight divided by the square of the height (kg/m2), office
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and 24-h systolic and diastolic BP (mm Hg), office HR
(beats/min1), serum cholesterol (mmol/l), diabetes
(present or absent), smoking habits (previous, current or
never), LV mass (g/m2.7) and antihypertensive treatment
at the time of follow-up contact (e.g., lifestyle measures
only, diuretics and beta-blockers alone or combined,
angiotensin-converting enzyme inhibitors and Ca2channel
blockers alone or combined, other drug combinations).
It is well-recognized that the E/A ratio decreases mark-
edly with increasing age and HR in both normotensive and
hypertensive patients (26). In the present population, we
found that the E/A ratio had a strong inverse relationship
with age (r 0.55) and HR (r 0.13, both p  0.001).
Therefore, analyses were adjusted for age and HR. In a
linear regression analysis, the E/A ratio was found to be a
dependent variable related to age and HR (multiple r 
0.63, p  0.0001). The following is the adjustment of the
E/A ratio based on the regression lines:
E/A ratioadjusted  E/A ratioobserved 
0.0199  age  50	
  0.0082  heart rate  75	

where the observed ratio is normalized for an individual’s
age (years) and HR (beats/min1) using the slopes of the
age- and HR-related regression lines. Using this formula,
the individual value of E/A ratio is normalized for an age of
50 years and HR of 75 beats/min. For the purpose of
survival analysis, the age- and HR-normalized E/A mitral
flow velocity ratio was modeled as either a binary or
continuous variable. Patients were categorized according to
whether their adjusted E/A ratio was below (n  919) or
above (n  920) the median value (0.036). We also tested
the independent prognostic value of the adjusted E/A ratio
as a continuous variable, as well as of the E-wave and
A-wave velocities taken separately. To explore whether the
relationship between the adjusted E/A ratio and the out-
come variable was better fitted by a J- or U-shape, we also
included in the model the square term of the adjusted E/A
ratio. The SPSS statistical package, release 8.0 (SPSS Inc.,
Chicago, Illinois), was used to perform the analyses. A p
value of  0.05 was considered as statistically significant.
RESULTS
Follow-up data were available in 1,839 (99%) of 1,856
patients, and only 1% of the patients were lost to follow-up.
We classified the study group into two subgroups with an
unadjusted E/A mitral velocity ratio below or above 0.98,
which is the median value of the population. As expected
from the inverse relationships depicted in Figure 1, patients
with a low E/A ratio were older (56  10 years vs. 45 
10 years) and had a higher HR (76  10 beats/min vs. 74 
10 beats/min), 24-h systolic/diastolic BP (140  16/88 
11 mm Hg vs. 134  14/86  10 mm Hg) and LV mass
(52  14 g/m2.7 vs. 47  13 g/m2.7).
Table 1 reports the main clinical and echocardiographic
characteristics of the study patients with an age- and
Figure 1. Bivariate relationships of the early/atrial (E/A) mitral velocity ratio with age, heart rate, left ventricular mass index and 24-h systolic blood
pressure. All p  0.001.
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HR-normalized E/A mitral velocity ratio lower or higher
than the median value. The two groups did not differ in
terms of age, gender distribution, smoking habits, diabetes,
serum cholesterol, duration of hypertension or left atrial
diameter. Patients with a low E/A velocity ratio had a
greater body mass index and higher office-visit and average
24-h systolic and diastolic BP values. In addition, the LV
mass was higher and the LV ejection fraction was lower in
patients with a low age- and HR-normalized E/A velocity
ratio.
During an average follow-up period of 4.4  2 years
(range: 1.0 to 10.8 years), there were 164 new cardiovascular
morbid events (2.04 events per 100 patient-years) and 55
all-cause deaths (0.66 deaths per 100 patient-years). Spe-
cifically, there were 31 patients with myocardial infarction,
4 who had a sudden cardiac death, 1 who had a cardiac
death from other causes, 21 with unstable angina, 11 with
coronary revascularization, 13 with heart failure that re-
quired hospital admission, 48 with stroke, 20 with transient
cerebral ischemia, 11 with new-onset aorto-iliac occlusive
disease and 4 with end-stage renal failure. We also regis-
tered a total of 87 new cardiac morbid events (1.06 events
per 100 patient-years), including 7 additional cardiac events
that occurred after a noncardiac event (3 myocardial infarc-
tions, 2 sudden cardiac deaths, 1 cardiac death from other
causes, 1 unstable angina).
Overall, there were 98 and 66 cardiovascular events in the
groups with a low (n  919) and high (n  920) age- and
HR-adjusted E/A mitral velocity ratio, respectively. The
incidence of cardiovascular events in the two groups was
2.47 and 1.65 per 100 patient-years, respectively, and the
cardiovascular event-free survival curves differed signifi-
cantly (p  0.005 by the log-rank test) (Fig. 2, lower panel).
When the analysis was restricted to cardiac morbid events,
the event rate was significantly higher in the group with a
low versus high adjusted E/A mitral velocity ratio (1.33 vs.
0.73 per 100 patient-years; p  0.01 by the log-rank test).
The event-free survival curves in patients with an unad-
justed E/A velocity ratio below or above the median value
are reported in Figure 2, upper panel.
Results of the multivariate survival analysis are reported
in Table 2. The E/A mitral velocity ratio maintained an
association with cardiovascular morbidity after adjustment
for the confounding effects of age, gender, smoking, diabe-
tes, cholesterol level, LV mass and average 24-h systolic BP.
Treatment status, 24-h diastolic BP, office-visit BP, HR,
body mass index and a family history of early-onset coronary
artery disease were included in the model, but failed to enter
the final equation. Patients with a low age- and HR-
adjusted E/A ratio had a 57% higher risk of cardiovascular
events (95% confidence interval [CI] 11% to 118%; p 
0.02). When the age- and HR-adjusted E/A mitral velocity
ratio was included in the multivariate model as a continuous
variable, a 21% higher risk of cardiovascular events was
found for each 0.3 decrease in the adjusted E/A mitral
velocity ratio (95% CI 2% to 43%; p  0.03). The
prognostic impact of the E/A velocity ratio remained
significant when the multivariate analysis was restricted to
cardiac morbid events. The higher risk of cardiac events
associated with the presence of a low age- and HR-adjusted
E/A ratio was 68% (95% CI 6% to 167%; p  0.03).
The incidence of all-cause deaths was 0.73 and 0.58 per 100
patient-years in the groups with a normalized E/A ratio
below and above the median value, respectively (p  0.48 by
the log-rank test). The prognostic impact of the E/A ratio
was not significant in Cox regression analysis (p  0.23).
Table 1. Clinical Characteristics of Study Subjects With an Age- and Heart Rate-Adjusted







(n  919) p Value
Age (yrs) 50.3  12 50.3  13 50.2  11 0.86
Male gender (%) 53 53 53 0.77
Body mass index (kg/m2) 26.7  4 26.2  4 27.1  4  0.001
Current smokers (%) 23 24 23 0.86
Diabetes (%) 5 6 5 0.27
Duration of hypertension (yrs) 4.2  6 4.0  6 4.3  6 0.24
Office-visit systolic BP (mm Hg) 156  19 155  18 157  19  0.01
Office-visit diastolic BP (mm Hg) 98  10 96  9 99  10  0.001
24-h systolic BP (mm Hg) 137  15 135  14 139  15  0.001
24-h diastolic BP (mm Hg) 87  10 85  9 89  10  0.001
Cholesterol (mmol/l) 5.53  1.1 5.50  1.0 5.56  1.1 0.23
LV diameter (mm) 49.4  5 49.1  5 49.6  5  0.03
LV mass (g/m2.7) 49.3  14 47.5  14 50.9  14  0.001
LV ejection fraction 0.66  0.09 0.67  0.09 0.66  0.08  0.01
Left atrial diameter (mm) 35.6  6 35.3  6 35.8  6 0.11
Peak E-wave velocity (m/s1) 0.63  0.17 0.72  0.15 0.56  0.14  0.001
Peak A-wave velocity (m/s1) 0.65  0.18 0.58  0.17 0.71  0.16  0.001
Peak E/A velocity ratio 1.04  0.40 1.31  0.40 0.82  0.23  0.001
E-wave velocity deceleration time (ms) 198  58 183  51 210  61  0.001
Data are presented as the mean value  SD or percentage of subjects.
BP  blood pressure; E/A  early/atrial; LV  left ventricular.
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We also examined the prognostic impact of the E-wave
and A-wave velocities, modeled as continuous variables.
Those patients who developed a cardiovascular event during
follow-up had a significantly lower E-wave velocity (0.57 
0.2 m/s1 vs. 0.64  0.16 m/s1; p  0.001) and a greater
A-wave velocity (0.71  0.2 m/s1 vs. 0.64  0.16 m/s1,
p  0.001). In a multivariate Cox regression model, the
prognostic value of the E-wave velocity was no longer
significant (odds ratio 0.87 for each 0.3-m/s1 increase;
95% CI 0.67 to 1.12; p  0.28), and the A-wave velocity
had a nonsignificant adverse prognostic value (odds ratio
1.24 for each 0.3-m/s1 increase; 95% CI 0.97 to 1.58; p 
0.09).
As expected, patients with a low E/A ratio had a signifi-
cantly longer E-wave velocity deceleration time (210  61 ms
vs. 183  51 ms, p  0.001), and an inverse relationship
was found between the E/A ratio and deceleration time (r
0.39; p  0.001). The E-wave velocity deceleration time
was significantly longer in those patients who had a cardio-
vascular event during follow-up (p  0.05). However, the
prognostic value of the E-wave velocity deceleration time
was no longer significant in a fully adjusted multivariable
model (hazards ratio 0.91 for each 50-ms increase, 95% CI
0.80 to 1.05, p  0.20).
DISCUSSION
The new finding of the present study is that the E/A
transmitral flow velocity ratio, a Doppler-derived index of
LV diastolic function, was predictive of subsequent cardio-
vascular morbid events in initially untreated and uncompli-
cated patients with essential hypertension. The relationship
between a low age- and HR-adjusted E/A mitral ratio and
future cardiovascular morbidity was statistically significant
and persisted after correction for the influence of several
traditional risk factors, including age, gender, diabetes,
cigarette smoking, LV mass, serum cholesterol level and
24-h ambulatory and office-visit BP.
Previous studies. Among the elderly participants in the
Cardiovascular Health Study, the E/A ratio represented an
independent risk factor for congestive heart failure (17). In
that study, both high and low Doppler E/A ratios were
predictive of incident heart failure, indicating that partici-
pants at either extreme of the velocity profile spectrum were
at increased risk of heart failure. However, those results
were obtained in a population whose age was 65 years and
in which the prevalence of hypertension was only 29% (17).
Among 3,107 patients undergoing cardiac catheterization,
the small subgroup (1.7%) with diastolic dysfunction, de-
fined as those with high LV end-diastolic pressure and no
systolic dysfunction, coronary heart disease or LV dilation
had a high risk of future cardiac morbid events (27), but no
comparison with the remaining patients was made in that
study. A transmitral flow pattern characterized by a short
isovolumic relaxation time and E-wave velocity deceleration
time and an increase in the E/A velocity ratio is a marker of
severely impaired LV compliance and elevated end-diastolic
filling pressures in patients with congestive heart failure
(28). This “restrictive” pattern of mitral inflow has been
recognized as a strong predictor of mortality in acute
myocardial infarction and congestive heart failure (12–15).
Taken together, the available studies do not provide an
Figure 2. Cardiovascular event-free survival in hypertensive patients whose
unadjusted (upper panel) or age- and heart rate-adjusted (lower panel)
early/atrial (E/A) mitral velocity ratio was below or above the median value.




Ratio (95% CI) p Value
Age (10 yrs) 1.77 (1.49–2.11) 0.001
Diabetes (yes or no) 2.52 (1.65–3.85) 0.001
Gender (men or women) 1.75 (1.24–2.49) 0.002
Cigarette smoking (yes or no) 1.64 (1.16–2.31) 0.006
24-h systolic BP (10 mm Hg) 1.22 (1.05–1.41) 0.01
Adjusted E/A ratio (below or
above median value)
1.57 (1.11–2.18) 0.01
Left ventricular mass (10 g/m2.7) 1.13 (1.02–1.24) 0.02
Serum cholesterol (mmol/l) 1.15 (1.00–1.33) 0.05
Family history of premature cardiovascular disease, office-visit blood pressure (BP),
24-h diastolic BP, heart rate, body mass index and treatment status failed to enter the
final equation.
CI  confidence interval; E/A  early/atrial.
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answer to the question regarding the prognostic impact of
LV diastolic filling abnormalities in hypertensive patients,
which are mostly characterized by abnormally prolonged
relaxation (6,9).
Present study. This is the first report of an association
between impaired early diastolic relaxation of the LV and
subsequent cardiovascular morbid events in a large, initially
untreated hypertensive population without prevalent cardio-
vascular disease at the baseline evaluation. The association
held after adjustment for several independent risk markers,
including age, male gender, smoking, diabetes and serum
cholesterol level. These findings were also independent of
echocardiographic LV mass, an established independent
predictor of cardiac morbidity and mortality in hypertension
(18,19), and average 24-h BP, which is a better risk marker
than office-visit BP in hypertensive patients (29).
Because a low E/A mitral velocity ratio is likely to be
associated with prolonged LV relaxation (6,8,9), our data
suggest that impaired LV relaxation is an independent
marker of an adverse prognosis in patients with hyperten-
sion. From a pathophysiologic standpoint, it is widely
established that the transmitral Doppler flow velocity pat-
tern is influenced by several conditions unrelated to ventric-
ular diastolic function, such as LV filling pressure, HR and
age, and that the simple assessment of the E/A flow velocity
ratio may not allow for separation of the effects of relaxation
and compliance on LV filling (30). Under certain circum-
stances, an increased or even normal E/A velocity ratio may
indicate decreased LV compliance (pseudonormal or restric-
tive filling pattern). These patterns cannot be easily distin-
guished from a normal filling pattern without taking into
account other variables, such as pulmonary vein flow or
mitral inflow responses to a preload reduction (8), which
require a more technically demanding and time-consuming
echocardiographic investigation that can rarely be sustained
in epidemiologic studies, such as PIUMA. Age and HR are
unlikely to have influenced our results, however, because in
the present study, the E/A velocity ratio was calculated after
taking into account the effect of age and HR. Furthermore,
our findings were obtained in a population without heart
disease and with a normal LV ejection fraction. A restrictive
LV filling pattern is a very uncommon finding in patients
without heart disease (31) and in hypertensive patients with
LV hypertrophy (32), representing 4% of the whole
population in those studies. Moreover, an E/A ratio 2 and
a deceleration time 150 ms, which have been proposed as
partition values for identifying patients with increased left
atrial pressure (33), were present in only 1.2% of our
population. Therefore, restrictive physiology is unlikely to
explain, to a significant extent, the normal to high E/A ratio
pattern observed in the present study. Moreover, we were
unable to show a J- or U-shaped relationship between the
E/A mitral ratio and subsequent cardiovascular events.
Because our hypertensive patients were asymptomatic and
unmedicated at the time of the initial echocardiographic
assessment, there was nothing to suggest that any of them
had extremely high or low preload. When significant
changes in loading conditions are not expected, as in this
study, the transmitral flow velocity pattern is useful to assess
gross LV diastolic performance (30).
The potential mechanisms underlying the association
between impaired LV relaxation and cardiovascular risk
remain hypothetical. The LV mass, a strong independent
risk marker in hypertension (18,19), was greater in patients
with a low adjusted E/A ratio (50.9  14 g/m2 vs. 47.5 
14 g/m2; p  0.001), but the adverse prognostic value of
the E/A ratio was consistently independent of LV mass in
a multivariate analysis (Table 2). The dependence on the
E/A ratio from cardiac loading conditions is well known
and cannot be completely accounted for in cross-sectional
studies. One possibility is that the E/A ratio and, for
extension, early diastolic relaxation might be very sensitive
to the whole load imposed on the LV, which cannot be fully
measured using BP recordings, not even on a 24-h basis. It
has been demonstrated that patients with diastolic heart
failure have a reduced aortic distensibility (34). Character-
istic aortic input impedance and arterial compliance have
not been considered in this study, but are likely to be
impaired in patients at higher risk of future cardiovascular
events.
Study limitations. Because our data were obtained in
initially untreated Caucasian patients, the results may not be
extended to different ethnic groups or to patients receiving
antihypertensive treatment at the time of the qualifying
examination. The PIUMA database does not include infor-
mation on BP control during follow-up in the whole
population; this information was available in 30% of the
study patients. Another limitation, inherent to observational
cohort studies, is the lack of control over occasional changes
in the antihypertensive regimen over time.
Conclusions. Our findings suggest an independent rela-
tionship between the baseline E/A mitral flow velocity ratio
and the risk of cardiovascular events in initially untreated
patients with essential hypertension. In these patients,
assessment of LV relaxation by transmitral Doppler echo-
cardiography may help to refine cardiovascular risk stratifi-
cation. A more aggressive therapeutic management may be
advisable for individuals with a low age- and HR-corrected
E/A velocity ratio. Future outcome studies should investi-
gate whether preventing or halting diastolic dysfunction
through antihypertensive treatment may lead to an im-
proved prognosis in hypertensive patients, independent of
an improvement in other markers of preclinical disease.
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